Clinical Trial Update: Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure [Phase 3]

View source ↗

Summary

Phase 3 trial comparing IMM-101 immunization to observation for preventing respiratory and severe COVID-19 infections in cancer patients at high exposure has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• IMM 101

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Cancer, Covid-19 | Phase 3 | Status: COMPLETED